RJA
MET icon

Ross\Johnson & Associates’s MetLife MET Stock Holding History

Ross\Johnson & Associates’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85 Buy
+1
New +$81 ﹤0.01% 306

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ross\Johnson & Associates's MET Position: Q2 2026 in Review

Ross\Johnson & Associates opened a new position in MetLife (MET) in Q2 2026: 1 share worth $85. The stake represents ﹤0.01% of the portfolio and ranks #306 among its holdings.

1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Ross\Johnson & Associates held 1 share of MetLife worth $85 as of Q2 2026.
  • MetLife was a new Ross\Johnson & Associates position in Q2 2026.
  • MetLife made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #306 holding.
  • 1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.